Last update 22 Mar 2025

[89Zr]Zr-DFO-emapalumab

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC)
Synonyms
Zirconium Zr 89-DFO-emapalumab
Target
IFNγ
Action
inhibitors
Mechanism
IFNγ inhibitors(Interferon gamma inhibitors)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication-
Inactive Indication
Non-Small Cell Lung Cancer
Originator Organization
Barbara Ann Karmanos Cancer InstituteBarbara Ann Karmanos Cancer Institute
Active Organization-
Inactive Organization
Barbara Ann Karmanos Cancer InstituteBarbara Ann Karmanos Cancer Institute
Drug Highest PhaseSuspendedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with [89Zr]Zr-DFO-emapalumab
NCT06439914
/ SuspendedPhase 1IIT
IFN-y PET Imaging: Bench to Bedside
100 Clinical Results associated with [89Zr]Zr-DFO-emapalumab
Login to view more data
100 Translational Medicine associated with [89Zr]Zr-DFO-emapalumab
Login to view more data
100 Patents (Medical) associated with [89Zr]Zr-DFO-emapalumab
Login to view more data
100 Deals associated with [89Zr]Zr-DFO-emapalumab
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerPhase 1
United States
Barbara Ann Karmanos Cancer InstituteBarbara Ann Karmanos Cancer Institute
25 Jun 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free